(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Scholar Rock Holding's revenue in 2025 is $0.On average, 6 Wall Street analysts forecast SRRK's revenue for 2025 to be $3,154,355,774, with the lowest SRRK revenue forecast at $318,290,833, and the highest SRRK revenue forecast at $16,382,616,425. On average, 7 Wall Street analysts forecast SRRK's revenue for 2026 to be $20,004,298,034, with the lowest SRRK revenue forecast at $8,029,354,347, and the highest SRRK revenue forecast at $53,173,292,168.
In 2027, SRRK is forecast to generate $37,113,179,249 in revenue, with the lowest revenue forecast at $20,941,664,539 and the highest revenue forecast at $68,806,988,985.